Last Updated: July 21, 2026

ISOPROTERENOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Isoproterenol, and what generic alternatives are available?

Isoproterenol is a drug marketed by 3M, Alpharma Us Pharms, Abraxis Pharm, Am Regent, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Avet Lifesciences, Baxter Hlthcare, Cipla, Deva Holding As, Eugia Pharma, Gland, Hikma, Hospira, Intl Medication, Micro Labs, Nexus, Penn Life, Pharmobedient, Somerset Theraps Llc, Zydus Pharms, Armour Pharm, DEY, and Parke Davis. and is included in thirty NDAs.

The generic ingredient in ISOPROTERENOL is isoproterenol hydrochloride. There are seventeen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the isoproterenol hydrochloride profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for ISOPROTERENOL?
  • What are the global sales for ISOPROTERENOL?
  • What is Average Wholesale Price for ISOPROTERENOL?
Summary for ISOPROTERENOL
US Patents:0
Applicants:26
NDAs:30
Drug Prices: Drug price information for ISOPROTERENOL
DailyMed Link:ISOPROTERENOL at DailyMed
Drug patent expirations by year for ISOPROTERENOL
Drug Prices for ISOPROTERENOL

See drug prices for ISOPROTERENOL

US Patents and Regulatory Information for ISOPROTERENOL

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dey ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 086764-001 Jan 4, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Parke Davis ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride SOLUTION;INHALATION 085994-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
3m ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride AEROSOL, METERED;INHALATION 010375-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 083346-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset Theraps Llc ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 211590-001 Aug 6, 2024 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amring Pharms ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 211237-001 May 19, 2021 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Am Regent ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 214775-001 Oct 19, 2022 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links